Methotrexate (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the Methotrexate drug offered from Pfizer Laboratories Div Pfizer Inc.. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
| NON-PROPRIETARY NAME: | Methotrexate |
| SUBSTANCE NAME: | METHOTREXATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
| ROUTE: | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-03-30 |
| END MARKETING DATE: | 0000-00-00 |
Methotrexate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Methotrexate from Pfizer Laboratories Div Pfizer Inc. |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2012-03-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0146_1419b93e-84c5-4d48-a4a5-9524447280d0 |
| PRODUCT NDC: | 0069-0146 |
| APPLICATION NUMBER: | ANDA201529 |
Other METHOTREXATE Pharmaceutical Manufacturers / Labelers:
